← Back to patent-cliff list
K-757
Tier C — Watch / tradeK-757
Kallyope Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：FFAR1
Indications (approved)：Obesity, Type 2 diabetes, 代谢病
Regional status
US
Phase II
2023-09-15
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of K-757?
Approved indications include: Obesity, Type 2 diabetes, 代谢病.
When does the K-757 patent expire?
No public expiry year is available for K-757 yet; this page updates once verified.
How do I get a quote for K-757 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-02